{"id":"https://openalex.org/W2102489196","doi":"https://doi.org/10.1158/1541-7786.mcr-10-0155","title":"Cholesterol Regulates VEGFR-1 (FLT-1) Expression and Signaling in Acute Leukemia Cells","display_name":"Cholesterol Regulates VEGFR-1 (FLT-1) Expression and Signaling in Acute Leukemia Cells","publication_year":2011,"publication_date":"2011-01-06","ids":{"openalex":"https://openalex.org/W2102489196","doi":"https://doi.org/10.1158/1541-7786.mcr-10-0155","mag":"2102489196","pmid":"https://pubmed.ncbi.nlm.nih.gov/21209384"},"language":"en","primary_location":{"id":"doi:10.1158/1541-7786.mcr-10-0155","doi":"https://doi.org/10.1158/1541-7786.mcr-10-0155","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1541-7786.mcr-10-0155","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080331399","display_name":"Cristina Casalou","orcid":"https://orcid.org/0000-0003-3198-2783","observed_orcids":["https://orcid.org/0000-0003-3198-2783"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]},{"id":"https://openalex.org/I48057805","display_name":"Instituto Gulbenkian de Ci\u00eancia","ror":"https://ror.org/04b08hq31","country_code":"PT","type":"education","lineage":["https://openalex.org/I4405252639","https://openalex.org/I48057805"]},{"id":"https://openalex.org/I83558840","display_name":"Universidade Nova de Lisboa","ror":"https://ror.org/02xankh89","country_code":"PT","type":"education","lineage":["https://openalex.org/I83558840"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Cristina Casalou","raw_affiliation_strings":["Authors' Affiliations:\u20081Angiogenesis Group, Instituto Portugu\u00eas de Oncologia Franscisco Gentil de Lisboa, EPE (CIPM/IPOLFG), Lisbon; 2Neoangiogenesis Group, Instituto Gulbenkian de Ci\u00eancia, Oeiras; 3CEDOC, Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal; and 4Imclone Systems, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Angiogenesis Group, Instituto Portugu\u00eas de Oncologia Franscisco Gentil de Lisboa, EPE (CIPM/IPOLFG), Lisbon; 2Neoangiogenesis Group, Instituto Gulbenkian de Ci\u00eancia, Oeiras; 3CEDOC, Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal; and 4Imclone Systems, New York","institution_ids":["https://openalex.org/I4210103180","https://openalex.org/I48057805","https://openalex.org/I83558840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017248857","display_name":"Ana Costa","orcid":"https://orcid.org/0000-0002-0893-3388","observed_orcids":["https://orcid.org/0000-0002-0893-3388"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]},{"id":"https://openalex.org/I48057805","display_name":"Instituto Gulbenkian de Ci\u00eancia","ror":"https://ror.org/04b08hq31","country_code":"PT","type":"education","lineage":["https://openalex.org/I4405252639","https://openalex.org/I48057805"]},{"id":"https://openalex.org/I83558840","display_name":"Universidade Nova de Lisboa","ror":"https://ror.org/02xankh89","country_code":"PT","type":"education","lineage":["https://openalex.org/I83558840"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Ana Costa","raw_affiliation_strings":["Authors' Affiliations:\u20081Angiogenesis Group, Instituto Portugu\u00eas de Oncologia Franscisco Gentil de Lisboa, EPE (CIPM/IPOLFG), Lisbon; 2Neoangiogenesis Group, Instituto Gulbenkian de Ci\u00eancia, Oeiras; 3CEDOC, Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal; and 4Imclone Systems, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Angiogenesis Group, Instituto Portugu\u00eas de Oncologia Franscisco Gentil de Lisboa, EPE (CIPM/IPOLFG), Lisbon; 2Neoangiogenesis Group, Instituto Gulbenkian de Ci\u00eancia, Oeiras; 3CEDOC, Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal; and 4Imclone Systems, New York","institution_ids":["https://openalex.org/I4210103180","https://openalex.org/I48057805","https://openalex.org/I83558840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044261553","display_name":"T\u00e2nia Carvalho","orcid":"https://orcid.org/0000-0002-5283-5013","observed_orcids":["https://orcid.org/0000-0002-5283-5013"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]},{"id":"https://openalex.org/I48057805","display_name":"Instituto Gulbenkian de Ci\u00eancia","ror":"https://ror.org/04b08hq31","country_code":"PT","type":"education","lineage":["https://openalex.org/I4405252639","https://openalex.org/I48057805"]},{"id":"https://openalex.org/I83558840","display_name":"Universidade Nova de Lisboa","ror":"https://ror.org/02xankh89","country_code":"PT","type":"education","lineage":["https://openalex.org/I83558840"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"T\u00e2nia Carvalho","raw_affiliation_strings":["Authors' Affiliations:\u20081Angiogenesis Group, Instituto Portugu\u00eas de Oncologia Franscisco Gentil de Lisboa, EPE (CIPM/IPOLFG), Lisbon; 2Neoangiogenesis Group, Instituto Gulbenkian de Ci\u00eancia, Oeiras; 3CEDOC, Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal; and 4Imclone Systems, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Angiogenesis Group, Instituto Portugu\u00eas de Oncologia Franscisco Gentil de Lisboa, EPE (CIPM/IPOLFG), Lisbon; 2Neoangiogenesis Group, Instituto Gulbenkian de Ci\u00eancia, Oeiras; 3CEDOC, Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal; and 4Imclone Systems, New York","institution_ids":["https://openalex.org/I4210103180","https://openalex.org/I48057805","https://openalex.org/I83558840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005540802","display_name":"Ana L. Gomes","orcid":"https://orcid.org/0000-0002-4796-6537","observed_orcids":["https://orcid.org/0000-0002-4796-6537"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]},{"id":"https://openalex.org/I48057805","display_name":"Instituto Gulbenkian de Ci\u00eancia","ror":"https://ror.org/04b08hq31","country_code":"PT","type":"education","lineage":["https://openalex.org/I4405252639","https://openalex.org/I48057805"]},{"id":"https://openalex.org/I83558840","display_name":"Universidade Nova de Lisboa","ror":"https://ror.org/02xankh89","country_code":"PT","type":"education","lineage":["https://openalex.org/I83558840"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Ana L. Gomes","raw_affiliation_strings":["Authors' Affiliations:\u20081Angiogenesis Group, Instituto Portugu\u00eas de Oncologia Franscisco Gentil de Lisboa, EPE (CIPM/IPOLFG), Lisbon; 2Neoangiogenesis Group, Instituto Gulbenkian de Ci\u00eancia, Oeiras; 3CEDOC, Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal; and 4Imclone Systems, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Angiogenesis Group, Instituto Portugu\u00eas de Oncologia Franscisco Gentil de Lisboa, EPE (CIPM/IPOLFG), Lisbon; 2Neoangiogenesis Group, Instituto Gulbenkian de Ci\u00eancia, Oeiras; 3CEDOC, Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal; and 4Imclone Systems, New York","institution_ids":["https://openalex.org/I4210103180","https://openalex.org/I48057805","https://openalex.org/I83558840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102120005","display_name":"Zhenping Zhu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]},{"id":"https://openalex.org/I48057805","display_name":"Instituto Gulbenkian de Ci\u00eancia","ror":"https://ror.org/04b08hq31","country_code":"PT","type":"education","lineage":["https://openalex.org/I4405252639","https://openalex.org/I48057805"]},{"id":"https://openalex.org/I83558840","display_name":"Universidade Nova de Lisboa","ror":"https://ror.org/02xankh89","country_code":"PT","type":"education","lineage":["https://openalex.org/I83558840"]}],"countries":["PT","US"],"is_corresponding":false,"raw_author_name":"Zhenping Zhu","raw_affiliation_strings":["Authors' Affiliations:\u20081Angiogenesis Group, Instituto Portugu\u00eas de Oncologia Franscisco Gentil de Lisboa, EPE (CIPM/IPOLFG), Lisbon; 2Neoangiogenesis Group, Instituto Gulbenkian de Ci\u00eancia, Oeiras; 3CEDOC, Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal; and 4Imclone Systems, New York","#N##TAB##TAB##TAB##TAB# Eli Lilly and Company#N##TAB##TAB##TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Angiogenesis Group, Instituto Portugu\u00eas de Oncologia Franscisco Gentil de Lisboa, EPE (CIPM/IPOLFG), Lisbon; 2Neoangiogenesis Group, Instituto Gulbenkian de Ci\u00eancia, Oeiras; 3CEDOC, Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal; and 4Imclone Systems, New York","institution_ids":["https://openalex.org/I4210103180","https://openalex.org/I48057805","https://openalex.org/I83558840"]},{"raw_affiliation_string":"#N##TAB##TAB##TAB##TAB# Eli Lilly and Company#N##TAB##TAB##TAB#","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yan Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]},{"id":"https://openalex.org/I48057805","display_name":"Instituto Gulbenkian de Ci\u00eancia","ror":"https://ror.org/04b08hq31","country_code":"PT","type":"education","lineage":["https://openalex.org/I4405252639","https://openalex.org/I48057805"]},{"id":"https://openalex.org/I83558840","display_name":"Universidade Nova de Lisboa","ror":"https://ror.org/02xankh89","country_code":"PT","type":"education","lineage":["https://openalex.org/I83558840"]}],"countries":["PT","US"],"is_corresponding":false,"raw_author_name":"Yan Wu","raw_affiliation_strings":["Authors' Affiliations:\u20081Angiogenesis Group, Instituto Portugu\u00eas de Oncologia Franscisco Gentil de Lisboa, EPE (CIPM/IPOLFG), Lisbon; 2Neoangiogenesis Group, Instituto Gulbenkian de Ci\u00eancia, Oeiras; 3CEDOC, Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal; and 4Imclone Systems, New York","#N##TAB##TAB##TAB##TAB# Eli Lilly and Company#N##TAB##TAB##TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Angiogenesis Group, Instituto Portugu\u00eas de Oncologia Franscisco Gentil de Lisboa, EPE (CIPM/IPOLFG), Lisbon; 2Neoangiogenesis Group, Instituto Gulbenkian de Ci\u00eancia, Oeiras; 3CEDOC, Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal; and 4Imclone Systems, New York","institution_ids":["https://openalex.org/I4210103180","https://openalex.org/I48057805","https://openalex.org/I83558840"]},{"raw_affiliation_string":"#N##TAB##TAB##TAB##TAB# Eli Lilly and Company#N##TAB##TAB##TAB#","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077594914","display_name":"S\u00e9rgio Dias","orcid":"https://orcid.org/0000-0002-7603-4616","observed_orcids":["https://orcid.org/0000-0002-7603-4616"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]},{"id":"https://openalex.org/I48057805","display_name":"Instituto Gulbenkian de Ci\u00eancia","ror":"https://ror.org/04b08hq31","country_code":"PT","type":"education","lineage":["https://openalex.org/I4405252639","https://openalex.org/I48057805"]},{"id":"https://openalex.org/I83558840","display_name":"Universidade Nova de Lisboa","ror":"https://ror.org/02xankh89","country_code":"PT","type":"education","lineage":["https://openalex.org/I83558840"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"S\u00e9rgio Dias","raw_affiliation_strings":["Authors' Affiliations:\u20081Angiogenesis Group, Instituto Portugu\u00eas de Oncologia Franscisco Gentil de Lisboa, EPE (CIPM/IPOLFG), Lisbon; 2Neoangiogenesis Group, Instituto Gulbenkian de Ci\u00eancia, Oeiras; 3CEDOC, Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal; and 4Imclone Systems, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Angiogenesis Group, Instituto Portugu\u00eas de Oncologia Franscisco Gentil de Lisboa, EPE (CIPM/IPOLFG), Lisbon; 2Neoangiogenesis Group, Instituto Gulbenkian de Ci\u00eancia, Oeiras; 3CEDOC, Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal; and 4Imclone Systems, New York","institution_ids":["https://openalex.org/I4210103180","https://openalex.org/I48057805","https://openalex.org/I83558840"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.749,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.67512955,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"9","issue":"2","first_page":"215","last_page":"224"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.4814000129699707,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.4814000129699707,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.2272000014781952,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12793","display_name":"Caveolin-1 and cellular processes","score":0.18950000405311584,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cholesterol","display_name":"cholesterol","score":0.9779999852180481},{"id":"https://openalex.org/keywords/flt-1","display_name":"Flt-1","score":0.8429999947547913},{"id":"https://openalex.org/keywords/vegfr1","display_name":"VEGFR1","score":0.9620000123977661},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9480000138282776},{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.9570000171661377},{"id":"https://openalex.org/keywords/lipid-rafts","display_name":"lipid rafts","score":0.7639999985694885},{"id":"https://openalex.org/keywords/caveolin-1","display_name":"caveolin-1","score":0.9980000257492065},{"id":"https://openalex.org/keywords/placental-growth-factor","display_name":"placental growth factor","score":0.9559999704360962},{"id":"https://openalex.org/keywords/vegf-signaling","display_name":"VEGF signaling","score":0.9419999718666077},{"id":"https://openalex.org/keywords/leukemia-cell-migration","display_name":"leukemia cell migration","score":0.6499999761581421},{"id":"https://openalex.org/keywords/methyl-beta-cyclodextrin","display_name":"methyl-\u03b2-cyclodextrin","score":0.8830000162124634},{"id":"https://openalex.org/keywords/nystatin","display_name":"nystatin","score":0.9390000104904175},{"id":"https://openalex.org/keywords/leukemia-cell-viability","display_name":"leukemia cell viability","score":0.5479999780654907},{"id":"https://openalex.org/keywords/disease-aggressiveness","display_name":"disease aggressiveness","score":0.7089999914169312},{"id":"https://openalex.org/keywords/bone-marrow","display_name":"bone marrow","score":0.7649999856948853}],"concepts":[{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.6935246586799622},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.6813289523124695},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6683399677276611},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5253459811210632},{"id":"https://openalex.org/C2776863199","wikidata":"https://www.wikidata.org/wiki/Q976388","display_name":"Acute leukemia","level":3,"score":0.4106115698814392},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2892250418663025}],"mesh":[{"descriptor_ui":"D000072483","descriptor_name":"Placenta Growth Factor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001854","descriptor_name":"Bone Marrow Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001854","descriptor_name":"Bone Marrow Cells","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002465","descriptor_name":"Cell Movement","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011257","descriptor_name":"Pregnancy Proteins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015973","descriptor_name":"Gene Expression Regulation, Leukemic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D021381","descriptor_name":"Protein Transport","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D021962","descriptor_name":"Membrane Microdomains","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D021962","descriptor_name":"Membrane Microdomains","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D040281","descriptor_name":"Vascular Endothelial Growth Factor Receptor-1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D040281","descriptor_name":"Vascular Endothelial Growth Factor Receptor-1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051242","descriptor_name":"Caveolin 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1541-7786.mcr-10-0155","doi":"https://doi.org/10.1158/1541-7786.mcr-10-0155","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1541-7786.mcr-10-0155","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"},{"id":"pmid:21209384","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21209384","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer research : MCR","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W20228888","https://openalex.org/W1975286848","https://openalex.org/W1988216718","https://openalex.org/W1990218923","https://openalex.org/W2010439346","https://openalex.org/W2020622102","https://openalex.org/W2028986871","https://openalex.org/W2044302244","https://openalex.org/W2051460435","https://openalex.org/W2058898263","https://openalex.org/W2067091621","https://openalex.org/W2069285055","https://openalex.org/W2082472490","https://openalex.org/W2091647214","https://openalex.org/W2129762213","https://openalex.org/W2131276314","https://openalex.org/W2132274201","https://openalex.org/W2136418873","https://openalex.org/W2145693683","https://openalex.org/W2166573361"],"related_works":["https://openalex.org/W2580160889","https://openalex.org/W2594047328","https://openalex.org/W2280640123","https://openalex.org/W2551607461","https://openalex.org/W2044302244","https://openalex.org/W2979549387","https://openalex.org/W2083402331","https://openalex.org/W7217686695","https://openalex.org/W2364361288","https://openalex.org/W2001550186"],"abstract_inverted_index":{"VEGF":[0,39,148],"receptors":[1],"1":[2],"(FLT-1)":[3],"and":[4,16,28,42,76,97,114,126,139,145,173,203],"2":[5],"(KDR)":[6],"are":[7,117],"expressed":[8],"on":[9,44,165],"subsets":[10,166],"of":[11,59,78,131,167],"acute":[12,17,79,168],"myeloid":[13],"leukemia":[14,19,45,142,152,193],"(AML)":[15],"lymphoid":[18],"cells,":[20],"in":[21,53,87,107,154],"which":[22,122,175],"they":[23],"induce":[24],"cell":[25,171],"survival,":[26],"proliferation,":[27],"migration.":[29],"However,":[30],"little":[31],"is":[32],"known":[33],"about":[34],"possible":[35],"cofactors":[36],"that":[37,50,69,84,98,160,191,204],"regulate":[38,73],"receptor":[40],"expression":[41,138],"activation":[43],"cells.":[46],"Here":[47],"we":[48,67,158,183],"show":[49],"cholesterol":[51,135,161,198,205],"accumulates":[52,86],"leukemia-rich":[54],"sites":[55],"within":[56],"bone":[57],"marrow":[58],"xenotransplanted":[60],"severe":[61],"combined":[62],"immunodeficient":[63],"(SCID)":[64],"mice.":[65],"Therefore,":[66],"hypothesized":[68],"cholesterol-rich":[70,89,109],"domains":[71,91],"might":[72],"FLT-1":[74,85,105,112,137],"signaling":[75,164],"chemotaxis":[77],"leukemias.":[80],"We":[81],"then":[82],"showed":[83],"discrete":[88],"membrane":[90],"where":[92],"it":[93],"associates":[94],"with":[95,208],"caveolin-1":[96],"placenta":[99],"growth":[100],"factor":[101],"(PlGF)/VEGF":[102],"stimulation":[103],"promotes":[104,140],"localization":[106,113],"such":[108],"domains.":[110],"Accordingly,":[111],"its":[115],"phosphorylation":[116],"abrogated":[118],"by":[119,127,150],"methyl-\u03b2-cyclodextrin":[120],"(M\u03b2CD),":[121],"removes":[123],"cellular":[124],"cholesterol,":[125],"nystatin,":[128],"an":[129],"inhibitor":[130],"lipid-raft":[132],"endocytosis.":[133],"Mechanistically,":[134],"increases":[136],"PlGF/VEGF-induced":[141],"cells":[143,153,194,202],"viability":[144],"also":[146],"induces":[147],"production":[149],"the":[151],"vitro.":[155],"Taken":[156],"together,":[157],"conclude":[159],"regulates":[162],"VEGF:VEGFR-1":[163],"leukemias,":[169],"modulating":[170],"migration,":[172],"viability,":[174],"may":[176],"be":[177],"crucial":[178],"for":[179],"disease":[180,209],"progression.":[181],"Finally,":[182],"provide":[184],"evidence":[185],"obtained":[186],"from":[187],"human":[188],"AML":[189],"samples":[190],"primary":[192],"accumulate":[195],"significantly":[196],"more":[197],"than":[199],"do":[200],"normal":[201],"accumulation":[206],"correlates":[207],"aggressiveness.":[210]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}